[Wen, Gebo; Zuo, Jianhong; Luo, Zhaoyang; Wen, GB; Lv, Xiu; Li, Sai; Wen, Juan] Univ South China, Sch Med, Hengyang 421001, Hunan, Peoples R China.

[Zuo, Jianhong; Lv, Xiu; Wen, Meiling; Li, Sai] Univ South China, Nanhua Hosp, Hengyang 421000, Hunan, Peoples R China.

[Lei, Mingsheng] Zhangjiajie City Hosp, Dept Resp & Crit Care Med, Zhangjiajie 427000, Hunan, Peoples R China.

[Luo, ZY; Wen, GB] U

Univ South China, Sch Med, Hengyang 421001, Hunan, Peoples R China.

beta actin;glucose transporter 1;hypoxia inducible factor 1alpha;nerve cell adhesion molecule;uvomorulin;vimentin;cadherin;CDH2 protein, human;glucose transporter 1;leukocyte antigen;SLC2A1 protein, human;vimentin;Article;cancer patient;cancer prognosis;cancer staging;cell migration;controlled study;epithelial mesenchymal transition;human;human cell;human tissue;hypoxia;immunohistochemistry;larynx cancer;larynx carcinoma;larynx squamous cell carcinoma;lymph node metastasis;priority journal;protein expression;survival rate;survival time;tumor invasion;Western blotting;aged;cell hypoxia;cell motion;larynx tumor;lymph node metastasis;metabolism;middle aged;mortality;pathology;physiology;squamous cell carcinoma;tumor cell culture;Aged;Antigens, CD;Cadherins;Cell Hypoxia;Cell Movement;Epithelial-Mesenchymal Transition;Glucose Transporter Type 1;Humans;Laryngeal Neoplasms;Lymphatic Metastasis;Middle Aged;Neoplasms, Squamous Cell;Survival Rate;Tumor Cells, Cultured;Vimentin

医学院